On Thursday, Conatus Pharmaceuticals Inc (NASDAQ:CNAT)’s shares dwindled -9.99%, and closed at $6.13, as the following news that Conatus Pharmaceuticals Inc (NASDAQ:CNAT) declared that it has priced an underwritten public offering of 3,500,000 shares of its ordinary stock at a price to the public of $5.75 per share. Gross proceeds, before underwriting discounts and commissions and estimated offering costs, are predictable to be about $20.1 million.
Conatus intends to use the net proceeds from the offering to fund clinical development of emricasan, counting preparation for registration trials, and for working capital and other general corporate purposes. Conatus has granted the underwriters a 30-day option to purchase up to 525,000 additional shares of its ordinary stock. The offering is predictable to close on or about April 8, 2015, subject to satisfaction of customary closing conditions.
Conatus Pharmaceuticals: a biotechnology corporation focuses on the development and commercialization of novel medicines to treat liver diseases in the United States. Its products comprise Emricasan, an orally active pan-caspase protease inhibitor, which is in Phase 2 clinical trials for the treatment of liver cirrhosis, acute-on-chronic liver failure, post liver transplant clearance of hepatitis C virus infection with sustained viral response, non-alcoholic steatohepatitis, and nonalcoholic fatty liver disease.
Ascent Solar Technologies, Inc (NASDAQ:ASTI)’s shares dropped -8.91%, and settled at $0.920, during the last trading session on Thursday, soon after Ascent Solar Technologies, Inc (NASDAQ:ASTI), declared four (4) of the corporation’s EnerPlex products won Red Dot Awards for Product Design from the Essen, Germany based awards conference: the Generatr 1200, Generatr 100, Jumpr Quad and Jumpr Stack series.
Robert Meck, Vice President of Product Engineering for EnerPlex said:
“We as a corporation are honored to have our products recognized by the esteemed Red Dot Organization. Red Dot is an internationally recognized symbol of innovative and quality design, and the four EnerPlex products awarded embody those standards powerfully.”
Ascent Solar Technologies: a development stage corporation, designs and manufactures photovoltaic integrated consumer electronics; and portable power applications for commercial and military users. The corporation offers Surfr, a battery and a solar case for the Apple iPhone 4/4S smart phone, in addition to for the Samsung Galaxy S III smart phone; EnerPlex Kickr, a portable solar charging device; and EnerPlex Jumpr, a portable power bank.
At the end of Thursday’s trade, TrueCar Inc (NASDAQ:TRUE)’s shares dipped -7.59%, and closed at $15.71, formerly on March 25, TrueCar Inc (NASDAQ:TRUE), declared that TrueCar administration took part in Bank of America Merrill Lynch’s 2015 New York Auto Summit to be held Wednesday, April 1, 2015, at the JW Marriott Essex House in New York City.
TrueCar Inc: operates as an Internet-based information, technology, and communication services corporation. The corporation operates its platform on the TrueCar Website and TrueCar mobile applications.
NuVasive, Inc (NASDAQ:NUVA), ended its Thursday’s trading session with -7.08% loss, and closed at $42.37, as NuVasive, Inc (NASDAQ:NUVA), stated that Greg Lucier, a member of the Corporation’s Board of Directors since 2013, has been designated to serve as Chairman of the Board and Interim Chief Executive Officer. This appointment follows Alex Lukianov’s resignation as Chief Executive Officer and a member of the Corporation’s Board.
- Gregory T. Lucier Designated Chairman and Interim Chief Executive Officer
- Alex V. Lukianov Steps Down as Chairman and Chief Executive Officer
- Corporation Anticipates 2015 First Quarter Proceed Will Exceed $190 Million, Counting More Than $2 Million of Currency Headwinds
NuVasive: a medical device corporation develops and markets minimally-disruptive surgical products and procedurally-integrated solutions for the spine. Its products focus on applications for spine fusion surgery.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
